JCU (4975) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Feb, 2026Executive summary
Net sales for 3Q FY3/26 (nine months ended December 31, 2025) increased by 3.8% year-over-year to ¥21,514 million.
Operating profit rose 16.4% to ¥8,887 million (or ¥9,003 million), and ordinary profit increased 13.2% to ¥9,003 million year-over-year.
Profit attributable to owners of parent was ¥6,578 million, up 19.9% year-over-year.
Financial highlights
Net sales grew to ¥21,514 million from ¥20,732 million year-over-year.
Comprehensive income for the nine months was ¥6,256 million, an 11.7% increase year-over-year.
Net income per share increased to ¥264.60 from ¥217.29 year-over-year.
Equity-to-asset ratio improved to 91.3% as of December 31, 2025, from 87.2% at March 31, 2025.
Total assets stood at ¥55,922 million, with net assets at ¥51,071 million as of December 31, 2025.
Outlook and guidance
Full-year net sales forecast revised to ¥29,200 million, up 3.0% year-over-year, with 3Q progress at 73.7%.
Full-year operating profit forecast at ¥11,600 million, up 10.3% year-over-year, with 3Q progress at 76.6%.
Ordinary profit is forecast at ¥11,800 million, up 8.1% year-over-year.
Profit attributable to owners of parent is expected to reach ¥8,500 million, up 13.4% year-over-year.
Full-year net income per share forecast at ¥342.43.
Latest events from JCU
- Strong profit and sales growth, share buyback, and positive full-year outlook.4975
Q1 202510 Dec 2025 - Profits and sales soared on electronics recovery, with robust cash flow and a positive outlook.4975
Q2 202510 Dec 2025 - Profits and sales soared on Asian electronics recovery, prompting an upward outlook revision.4975
Q3 202510 Dec 2025 - Double-digit profit growth, higher dividends, and stable FY2026 outlook with currency risk.4975
Q4 202510 Dec 2025 - Strong 1Q profit growth and solid progress toward annual targets, led by chemicals.4975
Q1 202610 Dec 2025 - Strong 1H FY3/26 growth in sales and profit, with positive outlook and higher dividends.4975
Q2 202610 Dec 2025